| Cash Flow | 2025-09-30 |
|---|---|
| Net income (loss) | 7,669 |
| Gain on disposal of assets | 483 |
| Provision for uncollectible accounts | 0 |
| Depreciation and amortization | 5,085 |
| Operating lease rentals | 1,562 |
| Loss on assets held for sale | 104 |
| Amortization of deferred financing costs | 213 |
| Stock-based compensation | 2,308 |
| Deferred income taxes | 247 |
| Other, net | 598 |
| Accounts receivable, net | -13,199 |
| Prepaid expenses and other current assets | 1,306 |
| Deposits and other | 950 |
| Accounts payable and accrued expenses | -24,303 |
| Reported and estimated claims | -368 |
| Due to medicaid and medicare | 1,908 |
| Operating lease liabilities | -1,559 |
| Net cash provided by (used in) operating activities | 3,924 |
| Purchases of property and equipment | 4,077 |
| Purchases of short-term investments | 453 |
| Proceeds from sale of assets held for sale | 3,716 |
| Net cash used in investing activities | -814 |
| Payments for finance lease obligations | 1,395 |
| Principal payments on long-term debt | 60,012 |
| Proceeds from the issuance of long-term debt | 60,082 |
| Payments on financing costs | 1,567 |
| Repurchase of equity securities | 0 |
| Contribution from joint venture partner | 3,200 |
| Taxes paid related to net settlements of stock-based compensation awards | 319 |
| Net cash used in financing activities | -11 |
| Net change in cash, cash equivalents and restricted cash including cash reclassified to assets held for sale | 3,099 |
| Less change in cash and restricted cash reclassified to assets held for sale | -82 |
| Increase (decrease) in cash, cash equivalents & restricted cash | 3,017 |
| Cash and cash equivalents at beginning of period | 64,140 |
| Cash and cash equivalents at end of period | 67,157 |
InnovAge Holding Corp. (INNV)
InnovAge Holding Corp. (INNV)